CreditAccess Grameen Ltd.

NSE: CREDITACC
NIFTY500
Analyst consensus:Constructive· 15 analysts
₹1,540.30+24.0%1Y
Last updated 06:19:42 IST· Public market feed (~15 min delay during market hours)

CreditAccess Grameen Ltd.: A 30-second snapshot

CreditAccess Grameen trades at ₹1,614, up 26.72% over the past year and 5.93% over the past 3 months, above both its 50-day (₹1,428.69) and 200-day (₹1,330.74) moving averages with an RSI of 65.69. Q1 FY27 PAT was reported at ₹490-493 crore, up roughly 720% YoY and 45% QoQ, alongside a trailing PE of 21.13, forward PE of 12.32, ROE of 16.36%, and a debt-to-equity ratio of approximately 3.0x typical of the NBFC-MFI lending model. Mean analyst rating stands at 1.56 across 15 analysts on a 1-5 scale (lower = more constructive).

P/E

21.1

Forward P/E

12.3

ROE

+16.4%

Debt / Equity

302.87

Profit Margin

+39.8%

Div. Yield

5Y ROE > 15%

2/5

5Y FCF > 0

1/5

Quality

61/100

Recent context

  • ·Q1 FY27 results (reported around July 24-27, 2026) showed PAT of ₹490-493 crore, up roughly 720% YoY and 45% QoQ, with AUM up 16.4% YoY; the Board approved NCD fund-raising of up to ₹3,000 crore.
  • ·All 8 recent headlines cover this single results event; the YoY comparison is measured against a depressed prior-year quarter during the microfinance sector's asset-quality stress period.
  • ·News sentiment across the period is entirely positive (8 of 8), concentrated around the earnings release rather than reflecting diverse coverage.

Strengths

  • +ROE of 16.36% ranks 1st of 6 among the listed peer set (AXISBANK, BAJAJFINSV, BAJFINANCE, HDFCBANK, HDFCLIFE).
  • +Forward PE of 12.32 compresses sharply from the trailing PE of 21.13, reflecting embedded earnings-growth expectations following the Q1 FY27 profit surge.
  • +Price trades above both the 50-day and 200-day moving averages, up 26.72% over 1 year and 5.93% over 3 months.
  • +Profit margin of 39.81% and mean analyst rating of 1.56 across 15 analysts (1-5 scale, lower = more constructive).

Weaknesses

  • 5-year persistence shows FCF positive in only 1 year and ROE above 15% in only 2 years, with a consistency score of 24/100 — a thin historical profitability base, though FCF for a lending business is structurally shaped by loan-book growth rather than directly comparable to a non-financial company.
  • Debt-to-equity of approximately 3.0x is on a rising trend; leverage is structurally elevated as is typical for the NBFC-MFI model.
  • Current price is 37% below its 52-week high despite trading above both moving averages, indicating the recovery has not yet returned to the prior peak.
  • Quality score of 58/100 ranks 3rd of 6 among peers, and the peer set (large private banks, a diversified NBFC, and a life insurer) does not include direct microfinance peers, limiting comparability.

Open questions

  • ?Does the roughly 720% YoY PAT growth reflect a durable improvement in asset quality and collections, or primarily a base effect from a depressed prior-year quarter during the sector's stress cycle?
  • ?How does the 5-year FCF and ROE persistence record (1 year FCF-positive, 2 years ROE above 15%) reconcile with the sharp earnings recovery reported this quarter?
  • ?What does the rising debt-to-equity trend imply for funding cost and credit spreads as the NCD fund-raising of up to ₹3,000 crore is executed?
  • ?Why does the current price remain 37% below its 52-week high even while trading above both the 50-day and 200-day moving averages, and what would close that gap?

Peer comparison: Banking

Ranks 3 of 6 on quality
SymbolNameP/EROEQuality
CREDITACCCreditAccess Grameen Ltd.You're viewing21.1+16.4%58
Industry avgacross 5 peers31.7+13.1%48
AXISBANKAxis Bank Ltd.13.8+13.3%70
HDFCBANKHDFC Bank Ltd.16.3+13.8%66
BAJFINANCEBajaj Finance Ltd.35.147
HDFCLIFEHDFC Life Insurance Company Ltd.59.9+10.8%33
BAJAJFINSVBajaj Finserv Ltd.33.3+14.6%23

Technical state

Current price

₹1,614.00

SMA 50

₹1,428.69

SMA 200

₹1,330.74

RSI (14)

65.7 (neutral)

From 52w high

-0.4%

1Y return

+26.7%

3M return

+5.9%

50-DMA

Above

200-DMA

Above

Algorithmic support levels

₹1,354.10
₹1,229.10
₹1,215.00

Risk flags

  • medium
    5-year persistence data shows ROE above 15% in only 2 of the years, FCF positive in only 1 of the years, and a consistency score of 24/100, alongside a rising debt-to-equity trend (raw metric 302.9 on Yahoo's percentage scale, approx. 3.0x on a standard multiple basis). This leverage level is structurally normal for an NBFC-MFI lender, and FCF for a growing loan book is dominated by disbursement/collection cash flows rather than directly comparable to a non-financial company's FCF, but the thin multi-year profitability persistence base is worth noting ahead of the recent Q1 FY27 earnings surge.
  • medium
    Current price of ₹1,614 sits 37% below its 52-week high even though it trades above both the 50-day SMA (₹1,428.69) and 200-day SMA (₹1,330.74), is up 26.72% over the past year, and up 5.93% over the past 3 months (RSI 65.69, neutral) — indicating a recovery trend that has not yet closed the gap to the prior peak.
  • low
    All 8 recent headlines cover a single event — Q1 FY27 results (PAT of ₹490-493 crore, up ~720% YoY and ~45% QoQ) — rather than reflecting diverse coverage; the YoY comparison is measured against a depressed prior-year quarter during the microfinance sector's asset-quality stress cycle, which inflates the percentage move.
  • low
    The listed peer set (AXISBANK, BAJAJFINSV, BAJFINANCE, HDFCBANK, HDFCLIFE) comprises large private banks, a diversified NBFC, and a life insurer rather than direct microfinance/NBFC-MFI peers, which limits comparability of the PE (rank 3/6), ROE (rank 1/6), and quality score (rank 3/6) rankings.

Cross-section contradictions

  • News coverage is uniformly positive (8 of 8 headlines) around Q1 FY27 PAT growth of roughly 720% YoY, but the comparison is against a depressed prior-year base from the sector's asset-quality stress period, and 5-year persistence data shows FCF positive in only 1 of the years — the single-quarter growth headline diverges from the multi-year profitability track record.
  • Mean analyst rating of 1.56 across 15 analysts (1-5 scale, lower = more constructive) sits toward the constructive end of the scale, while the 5-year consistency score is only 24/100 with ROE above 15% in just 2 of the years — sell-side positioning contrasts with a comparatively thin multi-year fundamental persistence record.

For informational purposes only. Not investment advice. VivaTrades is not a SEBI-registered Investment Adviser or Research Analyst. Market data sourced from public feeds; consult a registered adviser before any investment decision.

Fundamentals & technicals: refreshed 11 Aug 2026 · refreshed daily at 01:00 IST

AI synthesis (narrative, snapshot, strengths/weaknesses, peer ranking): generated 31 Jul 2026 · rotates through NIFTY 500 every ~5 days